PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth

2025-09-08
(Press-News.org)

‘Rogue’ DNA Rings Reveal Earliest Clues to Deadly Brain Cancer’s Growth

An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes – known as extrachromosomal DNA, or ecDNA – can drive the growth of a large proportion of glioblastomas, the most common and aggressive adult brain cancer. The discovery could open the door to much-needed new approaches to diagnose glioblastoma early, track its progress and treat it more effectively.

The findings, published today in Cancer Discovery, are the first to suggest that ecDNA rings containing cancer-driving genes often appear in the earliest stages of glioblastoma’s development – and in some cases, even before the tumour has fully formed. This early arrival may set the stage for the cancer’s rapid growth, adaptability and resistance to treatment. 

The study was led by Dr Benjamin Werner at Queen Mary University of London and Professor Paul Mischel at Stanford University, both part of Cancer Grand Challenges’ team eDyNAmiC, as well as Professor Charlie Swanton at The Francis Crick Institute.

Tackling cancer’s toughest challenges

Glioblastoma is one of the most challenging cancers to treat, with median survival remaining at around 14 months and little improvement in recent decades. New approaches for earlier detection and more effective treatment are urgently needed. 

ecDNA is emerging as a potentially important player in many adult and paediatric cancers, including glioblastoma, but its role is complex and mysterious. The Cancer Grand Challenges initiative – founded by Cancer Research UK and the National Cancer Institute in the US –  identified understanding ecDNA as one of the toughest challenges facing the field today. In 2022, they funded team eDyNAmiC – a $25m international, cross-disciplinary consortium of experts in cancer, clinical research, evolutionary biology, computer science and mathematics – to decipher ecDNA’s role and identify ways to target it. The current study marks an important advance in team eDyNAmiC’s work.

Excavating a tumour’s past

In their new study, team eDyNAmiC and their collaborators integrated genomic and imaging data from patients with glioblastoma with advanced computational modelling of the evolution of ecDNAs in space and time.

“We studied the tumours much like an archaeologist would. Rather than taking a single sample, we excavated multiple sites around the tumour, allowing us to build computational models describing how they evolved. We simulated millions of different scenarios to reconstruct how the earliest ecDNAs emerged, spread, and drove tumour aggressiveness, giving us a clearer picture of the tumour’s origins and progression,” explains senior author Dr Benjamin Werner, a group leader at the Barts Cancer Institute, Queen Mary University of London. 

The analysis revealed that most ecDNA rings contained EGFR, a potent cancer-driving gene. EGFR ecDNA appeared early in the cancer’s evolution – even before tumour formation in some patients. It also frequently gained extra changes, such as the EGFRvIII variant, that made the cancer more aggressive and resistant to therapies. 

A window of opportunity

“These subtle mechanisms show that there may be a window of opportunity to detect and treat the disease between the first appearance of EGFR ecDNA and the emergence of these more aggressive variants,” suggests Dr Magnus Haughey, a postdoctoral researcher in Dr Werner’s group and one of the paper’s lead authors. “If scientists can develop a reliable test to detect early EGFR ecDNA – for example through a blood test – it could enable them to intervene before the disease becomes harder to treat.”

The study confirmed that ecDNA can carry more than one cancer gene at a time, each of which may uniquely shape how tumours evolve and respond to treatment. This highlights the potential value of tailoring treatments based on a tumour’s ecDNA profile.

Yet many mysteries remain. The researchers now plan to study how different treatments affect the number and types of ecDNA in glioblastoma. Team eDyNAmiC will continue to investigate the role of ecDNAs across a range of cancer types to uncover further opportunities to diagnose cancers earlier, track their progress more precisely, and design smarter treatments.

Charlie Swanton, Deputy Clinical Director and head of the Cancer Evolution and Genome Instability Laboratory at The Francis Crick Institute and chief clinician at Cancer Research UK, says: 

“These findings suggest that ecDNA is not just a passenger in glioblastoma, but an early and powerful driver of the disease. By tracing when and how ecDNA arises, we open up the possibility of detecting glioblastoma much earlier and intervening before it becomes so aggressive and resistant to therapy. I hope this might help to drive a new era in how we diagnose, track and treat this devastating cancer.”

Paul Mischel, MD, the Fortinet Founders Professor and professor and vice chair of research in the pathology department at Stanford Medicine, says:

“These findings reveal an important new insight into the role of ecDNA in tumour development and progression. Previous work from our collaborative team and other researchers, has shown that ecDNA can arise early in tumor development, including at the stage of high-grade dysplasia, and it can also arise later to drive tumor progression and treatment resistance. The findings here show that in glioblastoma, there is an early event driven by ecDNA that could potentially be more actionable, raising the possibility that glioblastoma is another cancer for which earlier detection and intervention based upon ecDNA may be possible.”

Director of Cancer Grand Challenges, Dr David Scott, says:

“This study exemplifies the bold, boundary-pushing science Cancer Grand Challenges was created to support. By unravelling the evolutionary history of ecDNA in glioblastoma, team eDyNAmiC is not only deepening our understanding of one of the most devastating cancers but also illuminating new paths for earlier detection and treatment. It’s a powerful reminder that when we bring together diverse disciplines and global talent, we can begin to solve the toughest problems facing cancer research.”

END



ELSE PRESS RELEASES FROM THIS DATE:

Clinical study deepens understanding of mesothelioma and opens the door to potential treatment options

2025-09-08
WASHINGTON – People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of surgery for this difficult to treat cancer.   Mesothelioma is a rare cancer that affects the tissue that lines many organs of the body. Approximately 30,000 cases are diagnosed every year worldwide, most of them in the pleura, or lining of the lungs. It occurs most often in people who have been exposed ...

New study and major data updates expand the Kids First data ecosystem

2025-09-08
The Gabriella Miller Kids First Pediatric Research Program (Kids First) has released its 36th study and introduced significant new data updates to two existing studies, further advancing efforts to uncover the genetic foundations of childhood cancers and congenital conditions. This brings the total data files available at the Kids First Data Resource Center (Kids First DRC) to more than 110,000.     WHO: Kids First, a program from the National Institutes of Health (NIH) WHAT: Announcing the latest data releases to the Kids First data ecosystem. Newly released and updated datasets are available publicly, including: CONGENITAL CONDITIONS Kids ...

Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks

2025-09-08
Every year, sea turtles hatch on Florida’s beaches and make their way from the sand to the ocean – a critical journey that determines their chances of survival. As these hatchlings navigate obstacles such as artificial lights, beach debris and predators like birds and crabs, a new hazard looms. Sargassum seaweed washing up on Florida’s shores in record amounts is more than just a nuisance for beachgoers – it’s becoming a serious threat to vulnerable sea turtle hatchlings. While it’s long been known that obstacles on the beach can slow down hatchlings and put ...

Scientists uncover key to decoupling economic growth from pollution in developing countries

2025-09-08
Balancing environmental conservation with economic progress is one of the most pressing challenges of our time. This is particularly difficult for many developing countries, which urgently need to lift their populations out of poverty while grappling with the increasing degradation of their environment. Unfortunately, a common belief is that these nations have to choose between economic growth and a clean environment—a situation made more complex by their reliance on foreign aid. While the United Nations Sustainable Development Goals provide a global roadmap for tackling such issues, ...

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

2025-09-08
Gastrointestinal (GI) complications, such as postoperative ileus (POI) and intra-abdominal infections (IAI), remain a major concern after radical cystectomy for bladder cancer. Even with advances in surgical techniques, including robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC), and the adoption of enhanced recovery protocols, these complications continue to affect a substantial proportion of patients. They not only prolong hospital stays but also increase patient morbidity, underscoring the need to identify risk factors beyond surgical technique alone. In a new study ...

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

2025-09-08
Barcelona, Spain (September 8, 2025, Noon CEST / UTC +2  ) — BMS-986504, a first-in-class methylthioadenosine (MTA)-cooperative protein arginine methyltransferase 5 (PRMT5) targeting agent, showed promising antitumor activity in heavily pretreated patients with MTAP-deleted non-small cell lung cancer (NSCLC), according to results from the Phase 1CA240-0007 trial presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC). MTAP, encoding the enzyme methylthioadenosine phosphorylase, is ...

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) ) — A multi-center, randomized phase III trial has found that a three-week hypofractionated radiotherapy (HypoRT) schedule with concurrent chemotherapy provides similar survival outcomes and reduced toxicity compared to the standard six-week conventional fractionated radiotherapy (ConvRT) schedule for patients with limited-stage small cell lung cancer (LS-SCLC). The results were presented today at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC). In hypofractionated ...

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2)  Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC). Despite half of lung cancers being diagnosed in people aged 75 or older, randomized evidence on screening outcomes in this age group is limited. Most national lung cancer screening programs, including the UK’s, stop at age 74. The U.S. Preventive ...

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2)  – Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC). Video-assisted thoracoscopic surgery (VATS) is currently the most common approach to perform pulmonary lobectomy in early-stage lung cancer. Advantages include reduced pain, fewer complications, faster recovery and improved quality-of-life. The adoption of VATS lobectomy ...

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2)  – Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest that adjuvant chemo-immunotherapy may reduce the risk of recurrence in patients with completely resected stage IB–IIIA non-small cell lung cancer (NSCLC) while maintaining an acceptable safety profile. Despite complete surgical resection (R0), early-stage NSCLC carries a substantial risk of recurrence and remains a leading cause of cancer-related ...

LAST 30 PRESS RELEASES:

Hiring in high-growth firms: new study explores the timing of organizational changes

Boosting work engagement through a simple smartphone diary

Climate change may create ‘ecological trap’ for species who can’t adapt

Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date

AI and omics unlock personalized drugs and RNA therapies for heart disease

2023 ocean heatwave ‘unprecedented but not unexpected’

Johns Hopkins researchers develop AI to predict risk of US car crashes

New drug combination offers hope for men with advanced prostate cancer

New discovery finds gene converts insulin-producing cells into blood-sugar boosters

Powerful and precise multi-color lasers now fit on a single chip

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

[Press-News.org] ‘Rogue’ DNA rings reveal earliest clues to deadly brain cancer’s growth